In this month's newsletter, learn about the newly cleared CorPath GRX System, where you can find us at TCT 2016, and more from Corindus.
            
Not rendering correctly? View this email as a web page here.
            
Main Header

Corindus

FDA Grants 510(k) Clearance to Next Generation CorPath GRX System

FDA Grants 510(k) Clearance to Next Generation CorPath GRX System

We are pleased to announce that the U.S. Food and Drug Administration (FDA) has given 510(k) clearance for the CorPath GRX System, the second generation of the CorPath Vascular Robotic System. CorPath GRX includes the introduction of robotic guide catheter control as well as improvements to workflow that will enable physicians to perform more complex interventions. CorPath GRX will be on display for the first time at the upcoming TCT 2016 conference.

Read the Press Release

Learn more about CorPath GRX

spac5.gif
Corindus Welcomes Suzette Jaskie & Jeff Lemaster to the Team

Corindus Welcomes Suzette Jaskie & Jeff Lemaster to the Team

We are pleased to welcome two new members to the Corindus team. Suzette Jaskie, former President and Chief Executive Officer of MedAxiom Consulting, joins Corindus as Vice President Global Medical Affairs. Ms. Jaskie will develop and execute best in class medical education programs focusing on robotic therapy. Jeff Lemaster, former Global Vice President, Marketing of C.R. Bard, Inc., joins as Chief Commercial Officer. Mr. Lemaster will lead and execute revenue and commercial strategy to drive growth and market adoption globally.

Learn More

spac5.gif
TCT2016_01.jpg
TCT 2016-Reserve your hands-on demonstration
TCT 2016-Reserve your seat
spac5.gif
Northwest Texas Healthcare System First in Texas to Launch a CorPath Vascular Robotic Program

Northwest Texas Healthcare System First in Texas to Launch a CorPath Vascular Robotic Program

For the first time in Texas, interventionalists and their patients have access to robotic therapy for percutaneous coronary intervention. Northwest Texas Healthcare System is the first hospital in the state to acquire the CorPath 200 System. "We are proud to be the first medical center in Texas to launch a CorPath Vascular Robotic Program," said Mark Crawford, CEO. "The adoption of the CorPath System at Northwest Texas Healthcare System truly emphasizes our continuous commitment to delivering state of the art technology to our patients and clinical community."

Click Here to Learn More

spac5
www.corindus.com

For more information on CorPath email: sales@corindus.com


CorPath 200 System is intended for use in the remote delivery and manipulation of coronary guidewires
and balloon/stent catheters during PCI procedures

CorPath 200 System is intended for use in the remote delivery and manipulation of guidewires and rapid exchange catheters during percutaneous vascular interventional procedures.



CE logo


The CorPath GRX is intended for use in the remote delivery and manipulation of guidewires and rapid
exchange balloon/stent catheters, and remote manipulation of guide catheters during percutaneous
coronary intervention (PCI) procedures.

RX   Caution: Federal law restricts this device to sale by or on the order of a physician.


Copyright Corindus, Inc.
309 Waverley Oaks Road, Suite 105, Waltham, MA 02452, US
Corporate Office: 508-653-3335 | Sales & Customer Service: 800-605-9635 | Fax: 508-232-6000

 

www.corindus.com | Contact us